Nathalie Compagnone
CEO, CSO
Biochemistry
ICDD Sas
France
Biography
Dr. Compagnone, formerly at executive positions in biotech companies dedicated to drug development in Neurodegenerative diseases, has used her professional experience and continued training in Healthcare industry management to start and run ICDD. Dr Compagnone is a trained neuroscientist, who received her Ph.D. in 1993 after completing an Engineering degree from ESA. She was the principal investigator of a research laboratory at the University of California, San Francisco (UCSF) prior to joining the pharmaceutical industry in 2004. Dr. Compagnone is specialized in system biology, molecular & cellular imaging, and image analysis. She has also trained in business management and received a certificate in Bioentrepreneurship (CBE) from UCSF, followed by the completion of an executive MBA program from IAE (Aix-en Provence), and a mini-MBA in the management of innovation from Rutgers University. She regularly completes modules from HEC executive education (Paris). Dr. Compagnone assumes the positions of CEO and CSO at ICDD.
Research Interest
Biochemistry, Drug Discovery